Navigation Links
Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results
Date:11/13/2008

t of traumatic acute spinal cord injury (SCI) by the European Commission. The European Commission's decision was adopted following the favorable opinion issued by the European Medicine Agency (EMEA) Committee of Orphan Medicinal Products (COMP) at their meeting on June 10 and 11, 2008.

-- Results of a preclinical study of ALSE-100 demonstrated that Rho inhibitors could be useful in promoting bone healing. The data were presented at the Australian and New Zealand Bone and Mineral Society Annual Meeting, August 28-30, 2008, in Melbourne, Australia.

-- A poster entitled: "Altropane(R) SPECT in Parkinson Disease patients and healthy controls" was presented at the 2nd International Symposium on Neuroimaging in Parkinson's Disease and Related Disorders, October 21-22, 2008, in Chatham, MA.

-- We amended the Option Agreement with BioAxone to extend the date by which we can exercise our option from October 27, 2008 to November 27, 2008.

Financial Highlights of the Third Quarter 2008

-- Cash, cash equivalents and marketable securities at September 30, 2008 totaled $1.3 million as compared to $4.2 million at December 31, 2007. Convertible notes payable totaled $33.3 million at September 30, 2008 as compared to $23.3 million at December 31, 2007.

-- Net loss attributable to common stockholders was $5.1 million, or $0.25 per share, for the third quarter of 2008, as compared to $4.7 million, or $0.23 per share, in the third quarter of 2007.

-- Research and development (R&D) expenses totaled $2.8 million in the third quarter of 2008 as compared to $2.5 million in the third quarter of 2007. The increase in R&D expenses was primarily due to higher Altropane clinical costs.

-- General and administrative (G&A) expenses totaled $1.7 million for the third quarter of 2008 as compared to $2.0 million in the third quarter of 2007. The decrease in G&A expenses was primarily related to lower legal, patent and consulting costs.

-
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Alseres Pharmaceuticals, Inc. Raises $5 Million
2. Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights
3. Alseres Pharmaceuticals to Host 2007 Financial Results Conference Call
4. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
5. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
6. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
7. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
8. Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group
9. Transcept Pharmaceuticals, Inc. to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
10. Pacira Pharmaceuticals, Inc. Adds Experienced Physician Dr. David St. Peter to Leadership Team
11. Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2015)... 2015 This year has been one ... US Patented Pearl’s Premium Ultra Low Maintenance Lawn ... country that are coming out of record bad weather. ... of major global concerns related to water, health, and ... the alternative to the standard, water-wasting, chemical-treated standard lawn. ...
(Date:5/20/2015)... 2015  Health eCareers, the healthcare industry,s online ... job seekers looking for the flexibility of short-term ... and online tool dedicated exclusively to temporary and ... SHIFT enables employers to quickly find and hire ... diem and other temporary positions, eliminating the time ...
(Date:5/20/2015)... SAN DIEGO , May 20, 2015 /PRNewswire/ ... today announced a collaboration with Celgene Corporation to ... novel genomic biomarkers that associate with patient response ... collaboration is intended to help accelerate patient access ... increasing efficiencies in clinical research and development and ...
(Date:5/20/2015)... France, Cambridge, MA (PRWEB) May 20, 2015 ... high quality transporter assay services for Drug-Drug Interactions ... and Rhenovia Pharma, a world leader in assessing ... Translational Quantitative Systems Pharmacology supported by biosimulation, announced ... , The agreement allows both companies to expand ...
Breaking Biology Technology:Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 3Cypher Genomics Collaborates with Celgene Corporation to Identify Novel Genomic Biomarkers 2Optivia Biotechnology Inc. and Rhenovia Pharma Sign Partnership Agreement 2Optivia Biotechnology Inc. and Rhenovia Pharma Sign Partnership Agreement 3
... Ill., Feb. 9 Sagent Pharmaceuticals, Inc., a,privately-held ... Cefazolin for injection, USP, an essential antibiotic used ... , The 500mg single-dose ... the 1g single-dose vials and 10g pharmacy bulk ...
... February 9 Debiopharm,Group (Debiopharm), a global ... conditions and particularly oncology, and,Pharmaleads SAS, a ... today announced the signature of an exclusive ... of a small molecule,called Debio 0827 or ...
... 9 /PRNewswire-Asia-FirstCall/ -- Yongye Biotechnology,International, Inc. (OTC Bulletin ... producer and distributor of nutrients for plants and,animals, ... announced that the,Company,s management will present at the ... Dana Point, California. , ...
Cached Biology Technology:Sagent Pharmaceuticals Announces Expansion of Cefazolin Product Line to Include Cefazolin for Injection, USP in 500mg Single-Dose Vial 2Debiopharm and Pharmaleads Sign License Agreement for Debio 0827 or PL37 in Treatment of Chronic Pain Conditions 2Debiopharm and Pharmaleads Sign License Agreement for Debio 0827 or PL37 in Treatment of Chronic Pain Conditions 3Yongye Biotechnology to Present at Roth Conference 2Yongye Biotechnology to Present at Roth Conference 3
(Date:5/19/2015)... 2015 Fingerprint Cards (FPC) has received ... FPC1155 and FPC1035 from one if its module partners. Deliveries ... Q3 2015 and the sensors will be used by smartphone ... for 2015 hereby amount to 740 MSEK to date. In ... MSEK and a number of smaller orders not separately communicated ...
(Date:5/19/2015)... Research and Markets ( ... the  "Genetic Testing Market Outlook 2018"  report ... ,A recent report, Genetic Testing Market Outlook ... current and future genetic testing market. A ... principles and types are covered in this ...
(Date:5/14/2015)... , May 14, 2015 Research and Markets ... of the "Fingerprint Sensors Market in Smart Mobile ... This report believes that 2014 was a watershed year ... Apple,s introduction of ,Apple Pay,. Apple gave fingerprint sensors ... mobile payment service. Fingerprint sensors are a must-have feature ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Global Genetic Testing Market Outlook 2018 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2
... Chevy Chase, MD Chinese women are less likely to develop ... enter menopause later than their peers, according to a recent ... of Clinical Endocrinology & Metabolism ( JCEM ). ... with a higher risk of developing osteoporosis. The risk was ...
... Just as a global positioning system (GPS) helps find your ... the body,s location as it moves through its surroundings. ... for how the brain performs this feat. The study, published ... neurons called grid cells ramp their activity up ...
... , , , , , , ... , , , ... and then cooking the foods that kids grew... , Click here for more information. ... , , , , , , ...
Cached Biology News:Researchers discover workings of brain's 'GPS system' 2School-based kitchen gardens are getting an A+ 2School-based kitchen gardens are getting an A+ 3
Anti-Mouse IgM Heavy Chain:FITC, Clone LO-MM-9, Monoclonal Antibody...
... Timp-4 has been reported in heart ... fibroblasts in cell culture conditions. ... TPA stimulates production of TIMP-4 in ... protein levels produced often require concentration ...
PI/RNase Staining Buffer Solution , 100 ml Consult technical datasheet for details....
Selenoprotein P Purified Anti-Mouse clone 35, Isotype Mouse IgG 2b , 50 µg Consult technical datasheet for details....
Biology Products: